Fresenius Medical Care AG (MEX:FME N) Piotroski F-Score: 8 (As of Jun. 26, 2026) — 33% Above Median


MEX:FME N Fresenius Medical Care AG MEX:FME N
50 GF Score
Price MXN778.14
GF Value MXN1,677.19
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Piotroski F-Score?

Fresenius Medical Care AG MEX:FME N 50 Piotroski F-Score is 8 as of Jun. 26, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates MEX:FME N with a GF Score™ of 50/100 and a GF Value™ of MXN1,677.19 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 652 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 97.39% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Fresenius Medical Care AG has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Fresenius Medical Care AG's Piotroski F-Score or its related term are showing as below:

MEX:FME N' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 9
Current: 8

During the past 13 years, the highest Piotroski F-Score of Fresenius Medical Care AG was 9. The lowest was 4. And the median was 6.

Fresenius Medical Care AG  (MEX:FME N) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Fresenius Medical Care AG Piotroski F-Score Related Terms


Fresenius Medical Care AG Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Piotroski F-Score Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 6.00 7.00 7.00 8.00

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 6.00 8.00 8.00

MEX:FME N vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Piotroski F-Score falls into.


MEX:FME N
50GF Score
Fresenius Medical Care AG MEX:FME N
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 4892.334 + 5916.586 + 6896.099 + 2450.133 = MXN20,155 Mil.
Cash Flow from Operations was 16829.656 + 15966.322 + 21119.505 + 4729.925 = MXN58,645 Mil.
Revenue was 104064.732 + 105174.49 + 106886.916 + 96149.668 = MXN412,276 Mil.
Gross Profit was 26373.064 + 26745.887 + 29272.377 + 24588.931 = MXN106,980 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(723999.862 + 679570.89 + 665020.419 + 653651.882 + 656006.548) / 5 = MXN675649.9202 Mil.
Total Assets at the begining of this year (Mar25) was MXN724,000 Mil.
Long-Term Debt & Capital Lease Obligation was MXN180,131 Mil.
Total Current Assets was MXN169,027 Mil.
Total Current Liabilities was MXN140,291 Mil.
Net Income was 3688.237 + 4655.456 + 1460.969 + 3344.551 = MXN13,149 Mil.

Revenue was 93995.302 + 104027.767 + 111043.762 + 107962.986 = MXN417,030 Mil.
Gross Profit was 23003.443 + 25046.324 + 27744.152 + 26186.009 = MXN101,980 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(619402.886 + 668437.256 + 710485.488 + 733041.363 + 723999.862) / 5 = MXN691073.371 Mil.
Total Assets at the begining of last year (Mar24) was MXN619,403 Mil.
Long-Term Debt & Capital Lease Obligation was MXN210,271 Mil.
Total Current Assets was MXN176,000 Mil.
Total Current Liabilities was MXN120,468 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Fresenius Medical Care AG's current Net Income (TTM) was 20,155. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Fresenius Medical Care AG's current Cash Flow from Operations (TTM) was 58,645. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=20155.152/723999.862
=0.02783861

ROA (Last Year)=Net Income/Total Assets (Mar24)
=13149.213/619402.886
=0.02122885

Fresenius Medical Care AG's return on assets of this year was 0.02783861. Fresenius Medical Care AG's return on assets of last year was 0.02122885. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Fresenius Medical Care AG's current Net Income (TTM) was 20,155. Fresenius Medical Care AG's current Cash Flow from Operations (TTM) was 58,645. ==> 58,645 > 20,155 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=180131.059/675649.9202
=0.26660413

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=210271.237/691073.371
=0.3042676

Fresenius Medical Care AG's gearing of this year was 0.26660413. Fresenius Medical Care AG's gearing of last year was 0.3042676. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=169026.918/140290.654
=1.20483377

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=175999.639/120468.166
=1.46096388

Fresenius Medical Care AG's current ratio of this year was 1.20483377. Fresenius Medical Care AG's current ratio of last year was 1.46096388. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Fresenius Medical Care AG's number of shares in issue this year was 275.246. Fresenius Medical Care AG's number of shares in issue last year was 293.413. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=106980.259/412275.806
=0.25948711

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=101979.928/417029.817
=0.2445387

Fresenius Medical Care AG's gross margin of this year was 0.25948711. Fresenius Medical Care AG's gross margin of last year was 0.2445387. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=412275.806/723999.862
=0.56944183

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=417029.817/619402.886
=0.67327716

Fresenius Medical Care AG's asset turnover of this year was 0.56944183. Fresenius Medical Care AG's asset turnover of last year was 0.67327716. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Fresenius Medical Care AG has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
Fresenius Medical Care AG (MEX:FME N) has a Piotroski F-Score of 8 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Fresenius Medical Care AG and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, Fresenius Medical Care AG's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Fresenius Medical Care AG ranks #17 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 2.6%.
Is Fresenius Medical Care AG's Piotroski F-Score too high?
Fresenius Medical Care AG's current Piotroski F-Score of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Fresenius Medical Care AG's value of 8 is 60% above this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #17 out of 652 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius Medical Care AG has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #17 out of 652 companies for Piotroski F-Score. This places Fresenius Medical Care AG in the top 3% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Fresenius Medical Care AG's value of 8 is 60% above this benchmark. Historically, Fresenius Medical Care AG's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Fresenius Medical Care AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Piotroski F-Score is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (MEX:FME N) is currently considered Possible Value Trap. The stock's GF Value™ is MXN1,677.19, compared to a current price of MXN778.14 — trading 53.6% below its estimated fair value. The current Piotroski F-Score is 8, which is 33% above median its 10-year median of 6.00 and 60% above the Healthcare Providers & Services industry median of 5.00. Fresenius Medical Care AG's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Fresenius Medical Care AG (MEX:FME N), the current Piotroski F-Score is 8 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of MXN778.14 is trading 53.6% below its estimated GF Value™ of MXN1,677.19. GuruFocus considers Fresenius Medical Care AG to be Possible Value Trap.

Key valuation signals for MEX:FME N:

  • Piotroski F-Score: 8 (33% above median its 10-year median of 6.00)
  • GF Value™: MXN1,677.19 vs. price of MXN778.14 (53.6% below fair value)
  • GF Score™: 50/100 with 4 warning signs
  • Industry Position: 60% above the Healthcare Providers & Services median (#17 of 652)

No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
50GF Score

Get the complete analysis for MEX:FME N

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN778.14
Price
MXN1,677.19
GF Value